Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the February 2025 issue of JCAD.

Dr. James Del Rosso discusses a recent supplement that reviews insights about the challenges faced by both patients and clinicians in managing vitiligo.

Dr. Del Rosso discusses potential adverse events that can occur when treating patients with trimethoprim-sulfamethoxazole.

Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the January 2025 issue of JCAD.

Dr. Del Rosso reviews some of the most impactful research developments and drug approvals seen by the dermatology world in 2024.

Dr. Del Rosso discusses warning signs of serious adverse events related to trimethoprim-sulfamethoxazole prescribed to patients with acne.

Dr. Song provides helpful clinical tips for treating patients with methotrexate. 

Dr. Song provides an extensive overview of what’s new and emerging in atopic dermatitis treatment.

Dr. Del Rosso discusses three exciting new indications for drugs in dermatology and how these approvals will impact clinical practice. 

Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the October 2024 issue of JCAD. 

Dr. Kircik discusses a recent FDA-approval of an IL-17 inhibitor that has demonstrated to be safe and effective in patients with psoriasis.

Dr. Del Rosso discusses how to provide the correct treatment for the various presentations of psoriasis along with the impact psoriatic arthritis can have on these patients.

Dr. Gelfand discusses how to treat patients with psoriasis in terms of cardiovascular risk. He encourages clinicians to educate their patients about these events and the potential side effects they present.

Dr. Del Rosso discusses ways in which he’s modified his consultation style when speaking to patients with psoriasis who are about to commence treatment with a biologic.

George Martin, MD, discusses the specific role TNF inhibitors play for the treatment of psoriasis along with an important safety implication to be aware of for treating patients during pregnancy.

Dr. Del Rosso discusses biologic options for treating patients with psoriasis and psoriatic arthritis as well as pregnant patients.

Dr. Stein Gold discusses insights from clinical trials on new and upcoming systemic agents for psoriasis, including deucravacitinib and bimekizumab. 

George Martin, MD, discusses TNF inhibitors for the treatment of psoriasis and how these classic biologic agents currently fit into the ever-expanding arsenal of drugs for psoriasis.

Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, reviews the mechanisms of action of currently available treatments for atopic dermatitis...

Nicole Keeter, MSHS, PA-C, describes how to implement various JAK inhibitors into practice for the treatment of atopic dermatitis, psoriasis, and alopecia areata. She discusses how utilizing these JAK inhibitors in the treatment of atopic derma...

After reviewing notable safety considerations for systemic and topical Janus kinase inhibitors for patients with atopic dermatitis, Nicole Keeter, PA-C, describes steps she has taken to become more comfortable prescribing these agents to her pa...

Dr. James Del Rosso reviews various common treatments for atopic dermatitis, specifically topical agents that have demonstrated effectiveness for patients.

Peter Lio, MD, Assistant Professor of Clinical Dermatology and Pediatrics at Northwestern University’s Feinberg School of Medicine, discusses the development of JAK inhibitors over the years, and reviews the increase in reliability among both o...

Dr. James Del Rosso discusses the benefits of topical JAK inhibitors over oral JAK inhibitors for the treatment of atopic dermatitis.

Lisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist with Ada West Dermatology in Boise, Idaho, reviews the role that Janus kinases (JAKs) play in the inflammatory process and the benefits of inhibiting this enzyme when...